Biocodex
Non-Profit & Charitable Organizations · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
7 Ave Gallieni, Gentilly, Ile-de-France,...Phone Number
+33 141243000Website
www.biocodex.comRevenue
$7.7 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
5
4
2
4
3
2
About Biocodex
Biocodex USA is a Silicon Valley-based pharmaceutical company dedicated to providing its customers with meaningful health care solutions, with an emphasis on gastroenterology and oncology supportive care. Flagship products are Florastor, the #1 selling probiotic worldwide, and Totect, the only treatment approved by the FDA for anthracycline extravasation in chemotherapy. Biocodex USA is a subsidiary of Biocodex, a family-owned multinational pharmaceutical, research, development, manufacturing and commercial enterprise operating in more than 100 countries.Explore more
Biocodex Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biocodex your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Biocodex, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Biocodex launches new products
Congratulate Masked Content for being promoted to Masked Content at Biocodex
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Biocodex is spiking on competitors!
Funding: Get notified immidiatlly once Biocodex has new funding data
Click to see if Biocodex had a recent Job posting/layoffs
Earning: See what the market has to say on Biocodex recently announced quarterly report
Check if Biocodex has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Biocodex as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Biocodex is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Biocodex is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Biocodex.
Biocodex Tech Stack
A closer look at the technologies used by Biocodex
Most Recent Scoops
Hiring Plans
Biocodex has more open roles in Medical & Health than it has had at any time in the past 9 months.
Hiring Plans
Hiring Plans
Biocodex has more open roles in Legal than it has had at any time in the past 12 months. Technologies mentioned include: Remote.
Hiring Plans
Hiring Plans
Biocodex has more open roles in Sales than it has had at any time in the past 6 months. Technologies mentioned include: Salesforce, and Como.
Hiring Plans
Hiring Plans
Biocodex has more open roles in Finance than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Hiring Plans
Biocodex News & Media
Biocodex Strengthens Supply Chain Resilience with Kinaxis
OTTAWA, Ontario--(BUSINESS WIRE)--Biocodex, a pioneer and leader in human microbiota health, as well as an innovator in pharmaceuticals, has partnered with Kinaxis® Inc. (TSX: KXS), a global leader in end-to-end supply chain orchestration, to modernize and optimize its processes. Through this collaboration, Biocodex aims to achieve greater forecast accuracy, simplify the management of regulatory challenges, and enhance resilience against disruptions. Biocodex is a French, family-owned, pharmaceCity of Hope's Dr. Alexis LeVee Awarded Biocodex Microbiota Foundation's 2024 USA National Research Grant
BEDMINSTER, N.J., Dec. 10, 2024 /PRNewswire/ -- The Biocodex Microbiota Foundation, an independent organization founded by Biocodex, has awarded its 2024 USA Microbiome Research Grant to Alexis LeVee, MD, Chief Hematology and Medical Oncology Fellow at City of Hope, a national cancer...New Development in Rare Pediatric Epilepsy: Biocodex Announces the Development of DIACOMIT® (stiripentol) Oral Suspension, a New Formulation to Aid in the Treatment of Dravet Syndrome in Young Children
BEDMINSTER, N.J., Nov. 14, 2024 /PRNewswire/ -- The global pharmaceutical company, Biocodex, a long-time pioneer in the treatment of rare pediatric diseases, is proud to announce they are developing a new oral-suspension formulation for DIACOMIT, an FDA-approved treatment indicated for...The Biocodex Group Strengthens Its Position in Microbiota, With the Signature of a Licensing Agreement With My Health, a Belgian Biotech Company Specializing in Microbiota Solutions
PARIS--(BUSINESS WIRE)--Biocodex, a French pharmaceutical group with expertise in microbiota, women's health, orphan diseases, and My Health, a Belgian biotech company specializing in microbiota solutions, announce that they have signed a licensing agreement covering several countries in which the Biocodex Group operates, to market the DUOSPORE® dietary supplement. My Health was founded in 2017 by Raf Dybajlo. In 2021, the company published a clinical study in The Lancet Gastroenterology &
Read more news
Top Non-Profit & Charitable Organizations Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biocodex
Sign Up For FreeTo access detailed company insights
Biocodex USA is a Silicon Valley-based pharmaceutical company dedicated to providing its customers with meaningful health care solutions, with an emphasis on gastroenterology and oncology supportive care. Flagship products are Florastor, the #1 selling probiotic worldwide, and Totect, the only treatment approved by the FDA for anthracycline extrava... Read More
